- TALLC issues new Corporate Presentation
- Dr. Damon Smith at Biotech Show Case
- TALLC at the Ophthalmology Innovation Summit
- TALLC Corporation Announces Grant of New SmartCelle Patent for Enhanced Ocular Delivery of TA-A001
- Tetra Bio-Pharma and Altus Formulation Form New Company “TALLC” to Exploit TA-A001
TALLC is an pioneering ophthalmology company focused on the unmet needs of patients with corneal and retinal conditions.
TALLC and IACTA to present at the H.C. Wainwright Bioconnect Conference: January 10-13, 2022
TALLC will present details of the SmartCelle insoluble drug delivery platform for ocular, parenteral and oral delivery and an update on t…https://lnkd.in/gAwAqwnQ